Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry
Richard Beale(St Thomas' Hospital), Konrad Reinhart(Charité - Universitätsmedizin Berlin), Mark D. Williams(English Institute of Sport), Charles L. Sprung(Hebrew University of Jerusalem), Greg S. Martin(Emory University), Amy G Leishman(Eli Lilly (United States)), B. Vallet(Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail), Eliezer Silva(Universidade Estadual da Paraíba), Frank M. Brunkhorst, Geoffrey Dobb(Royal Perth Hospital), Graham Ramsay(Radboud University Nijmegen), Timothy M. Costigan(Eli Lilly (United States)), Mitchell M. Levy(Brown University), Jonathan Janes(Eli Lilly (United States)), Jean‐Louis Vincent(Université Libre de Bruxelles)
Cited by 84
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k